Cipla

Sovereign Pharma releases first batch of remdesivir to Cipla

Read more

Experts ask govt to ensure access to remdesivir, raise concerns about supply shortage

Read more

Mylan gets approval to make and market remdesivir

Read more

Cipla and Boehringer Ingelheim to co-market three oral anti-diabetic drugs

Read more

Cipla to price remdesivir version for COVID-19 under 5,000 rupees

Read more

Cipla launches remdesivir under brand name CIPREMI

Read more

Maha govt plans to procure 10000 vials of remdesivir from Cipla

Read more

Cipla, Hetero get DCGI nod to manufacture remdesivir

Read more

Cipla and Roche partner up to improve access to oncology medicines

Read more

Centre clarifies reasons for delay in approvals for remdesivir

Read more